PATHOGENETIC ASPECTS OF ALLERGIZATION OF THE BODY OF CHILDREN WITH ATOPIC DERMATITIS AND ECZEMA

Authors:

Abstract:

The presented article examines the differences in the pathogenesis of atopic dermatitis and infantile eczema, which are mainly determined by the specific features of the immune response. It is shown that IgE – dependent mechanisms play a key role in the development of pathological processes in atopic dermatitis, whereas infantile eczema demonstrates a distinct immunological pattern. The difference in allergization mechanisms determines the varying spectrum of skin reactivity in these groups of patients, manifested by diverse clinical symptoms and variations in disease progression. Particular attention is given to the level of sensitization as an important diagnostic and prognostic marker that should be considered when designing individualized therapeutic and dietary strategies. The findings highlight the need for a differentiated approach to managing children with atopic dermatitis and infantile eczema, taking into account the immunological, clinical, and allergological characteristics of each patient.

Keywords:

atopic dermatitis childhood eczema allergization

References:

1. Bai R, Zheng Y, Dai X. Atopic dermatitis: diagnosis, molecular pathogenesis, and therapeutics. Mol Biomed. 2025; 6(1): 71-87. doi: 10.1186/s43556-025-00313-3.
2. Bylund S, Kobyletzki LB, Svalstedt M, et al. Prevalence and Incidence of Atopic Dermatitis: A Systematic Review. Acta Derm Venereol 2020; 5(2): 123-132. doi: 10.2340/00015555-3510.
3. Chang L-S, Li J-H, Wang P-M, Huang C-F, Kuo H-C. Association between Serum Total and Specific Immunoglobulin E Levels and Body Height: A Cross-Sectional Study of Children and Adolescents. Children. 2022; 9(5): 66-71. doi:10.3390/children9050661.
4. Jeskey J, Kurien C, Blunk H, Sehmi K, Areti S, Nguyen D, Hostoffer R. Atopic Dermatitis: A Review of Diagnosis and Treatment. J Pediatr Pharmacol Ther. 2024; 29(6):587-603. doi: 10.5863/1551-6776-29.6.587.
5. Maiello N, Giannetti A, Ricci G, Cinicola B, Carello R, Indolfi C, et al. Atopic dermatitis and atopic march: which link? Acta Biomed. 2021; 29 (7): 202-215. doi: 10.23750/abm.v92iS7.12430.
6. Meng J, Xiao H, Xu F, She X, Liu C, Canonica GW. Systemic barrier dysfunction in type 2 inflammation diseases: perspective in the skin, airways, and gastrointestinal tract. Immunol Res. 2025; 73(1): 60-73. doi: 10.1007/s12026-025-09606-9.
7. Tao R, Li R and Wang R. Dysbiosis of skin mycobiome in atopic dermatitis. Mycoses 2022; 65: 285–293. doi: 10.1111/myc.13402.
8. Tay ASL, Li C, Nandi T. Atopic dermatitis microbiomes stratify into ecologic dermotypes enabling microbial virulence and disease severity. Journal of Allergy and Clinical Immunology 2020; 53(1): 161-175. doi: 10.1016/j.jaci.2020.09.031.
9. Tham EH, Chia M, Riggioni C, Nagarajan N, Common JEA, Kong HH. The skin microbiome in pediatric atopic dermatitis and food allergy. Allergy. 2024; 79(6):1470-1484. doi: 10.1111/all.16044.
10. West CE, Rydén P, Lundin D, Engstrand L, Tulic MK, Prescott SL. Gut microbiome and innate immune response patterns in IgE-associated eczema. Clin Exp Allergy. 2025; 45(9): 1419-29. doi: 10.1111/cea.12566.
11. Wollenberg A, Christen-Zäch S, Taieb A, Paul C, Thyssen JP, de Bruin-Weller M, et al. European Task Force on Atopic Dermatitis/EADV Eczema Task Force. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatol Venereol. 2020; 34(12): 2717-2744. doi: 10.1111/jdv.16892.
12. Wollenberg A, Thomsen SF, Lacour JP, Jaumont X, Lazarewicz S. Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence. World Allergy Organ J. 2021; 14(3): 105-119. doi: 10.1016/j.waojou.2021.100519.
13. Yang G, Seok JK, Kang HC, Cho YY, Lee HS, Lee JY. Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis. Int J Mol Sci. 2020; 21(8): 128-137. doi: 10.3390/ijms21082867.
14. Yue C, Zhou H, Wang X, Yu J, Hu Y, Zhou P, et al. Atopic dermatitis: pathogenesis and therapeutic intervention. MedComm. 2024; 8(5): 112-123. doi: 10.1002/mco2.70029.

Publication:

«World of Medicine and Biology» Vol. 21 No. 94 (2025) , с. 61-65
УДК 616.513/.521-092-053.2

DOI:

https://doi.org/10.26724/2079-8334-2025-4-94-61-65